ask="0.68"
ask_size="6300"
average_daily_volume="811518"
bid="0.52"
bid_size="1000"
book_value="0.81"
change="-0.01"
change_from_200_day_moving_average="-0.02"
change_from_50_day_moving_average="0.01"
change_from_52_week_high="-0.87"
change_From_52_week_low="0.22"
change_in_percent="-1.31%"
close="0.55"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.54"
ebitda="-17.93M"
eps_estimate_current_year="-0.78"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.57"
ex_dividend_date="N/A"
float_shares="29627000"
high="0.58"
high_52_weeks="1.42"
last_trade_date="1/26/2017"
last_trade_price="0.55"
last_trade_size="400"
last_trade_time="3:58pm"
low="0.55"
low_52_weeks="0.33"
market_capitalization="16.51M"
moving_average_200_day="0.57"
moving_average_50_day="0.54"
name="OncoGenex Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="0.90"
open="0.58"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-3.90%"
percent_change_from_50_day_moving_average="+2.14%"
percent_change_from_52_week_high="-61.26%"
percent_change_from_52_week_low="+66.16%"
previous_close="0.56"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.69"
price_per_sales="1.51"
revenue="11.09M"
shares_outstanding="30020000"
short_ratio="1.39"
stock_exchange="NCM"
symbol="OGXI"
volume="71873"
weeks_range_52="0.33 - 1.42"
